Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-25 @ 4:26 AM
NCT ID:
NCT00059020
Eligibility Criteria:
INCLUSION CRITERIA:
Radiographic evidence of a primary glial neoplasm of the CNS (WHO grade II-IV) or any patient with known primary neoplasms of the CNS.
Medically indicated diagnostic and/or therapeutic tumor resection.
Informed consent from patient, age 18 or older to 75 years of age.
Females of child-bearing capacity: Pregnant women will be entered into the study for tumor collection, but blood will not be drawn at the time of surgery. Six weeks or more after the completion of pregnancy, these women will be contacted and 10cc (2 tsp) of blood will be collected for genotyping.
No racial or ethnic group or gender is excluded.
EXCLUSION CRITERIA:
Inability to provide informed consent prior to surgery.
Medical conditions that cannot be corrected prior to surgery that would be standard contraindications for neurosurgery.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00059020
Study Brief:
Protocol Section:
NCT00059020